ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s share price rose 0.8% on Friday . The stock traded as high as C$6.70 and last traded at C$6.50. Approximately 19,980 shares traded hands during trading, an increase of 3% from the average daily volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Up 0.8 %
The company has a current ratio of 5.06, a quick ratio of 4.29 and a debt-to-equity ratio of 1.70. The firm has a market capitalization of C$162.08 million and a P/E ratio of -7.30. The stock’s 50-day simple moving average is C$6.50 and its 200-day simple moving average is C$6.50.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- 3 REITs to Buy and Hold for the Long Term
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Calculate Inflation Rate
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Industrial Products Stocks Investing
- Time to Load Up on Home Builders?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
